期刊文献+

炎症在帕金森病中的作用 被引量:9

Inflammation in Parkinson's Disease (review)
下载PDF
导出
摘要 帕金森病是中老年人常见的神经变性疾病,以黑质致密部多巴胺能神经元进行性缺失、纹状体多巴胺水平降低为主要特点。中枢神经系统炎症和全身炎症都会导致多巴胺能神经元变性和死亡;抑制中枢神经炎症,靶向调节全身炎症、减轻外周损伤对大脑的影响,有助于缓解和阻止病情的发展,给帕金森病的预防和治疗提供新思路。 Parkinson’s disease is a common progressive neurodegenerative disorder among old people,characterized by progressive loss of dopamine-producing neurons in the substantia nigra pars compacta and accordingly low level of dopamine in the nigrostriatal pathway.Neuroinflammation and even systemic inflammation have been suggested to be involved in the demise of dopaminergic neurons.Anti-inflammatory treatment could protect brain from inflammatory injury and prevent the progressive course of Parkinson’s disease,which suggests a potential new strategy for Parkinson’s disease treatment.
出处 《中国康复理论与实践》 CSCD 北大核心 2013年第7期640-644,共5页 Chinese Journal of Rehabilitation Theory and Practice
基金 科技部"十二五"重大创新药专项(No.2012ZX09102-201-016) 国家自然科学基金(No.81173575) 国家自然科学基金(No.30740053) 北京市自然科学基金(No.7062031) 北京市教委科研基地-科技创新平台(No.111219) 北京市卫生系统高层次卫生技术人才(No.2011-3-097)
关键词 帕金森病 神经炎症 全身炎症 综述 Parkinson’s disease neuroinflammation systemic inflammation review
  • 相关文献

参考文献48

  • 1Bekris LM, Mata IF, Zabetian CP, et al. The genetics of Parkin-son disease [J]. J Geriatr Psychiatry Neurol, 2010,23(4):228-242.
  • 2Tansey MG, Goldberg MS. Neuroinflammation in Parkinson'sdisease: its role in neuronal death and implications for thera-peutic intervention [J]. Neurobiol Dis, 2010,37(3): 510-518.
  • 3Frank-Cannon TC, Alto LT, McAlpine FE, et al. Does neuroin-flammation fan the flame in neurodegenerative diseases. [J].Mol Neurodegener, 2009,4: 470.
  • 4McGeer PL, Itagaki S, Boyes BE, et al. Reactive microglia arepositive for HLA-DR in the substantia nigra of Parkinson's andAlzheimer's disease brains [J]. Neurology, 1988, 38(8):1285-1291.
  • 5Zhou Y,Zhang Y,Li J, et al. A comprehensive study onlong-term injury to nigral dopaminergic neurons following in-tracerebroventricular injection of lipopolysaccharide in rats [J].J Neurochem, 2012. doi: 10.1111/jnc.12010.
  • 6Ouchi Y, Yagi S,Yokokura M,et al. Neuroinflammation in theliving brain of Parkinson's disease [J]. Parkinsonism Relat Dis-ord, 2009, 15(Suppl 3): 200-204.
  • 7Long-Smith CM, Collins L,Toulouse A,et al. Interleukin-1 be-ta contributes to dopaminergic neuronal death induced by lipo-polysaccharide-stimulated rat glia in vitro [J], J Neuroimmu-nol, 2010, 226(1-2): 20-26.
  • 8De Leila Ezcurra AL, Chertoff M, Ferrari C, et al. Chronic ex-pression of low levels of tumor necrosis factor-alpha in the sub-stantia nigra elicits progressive neurodegeneration, delayed mo-tor symptoms and microglia/macrophage activation [J]. Neuro-biol Dis, 2010,37(3): 630-640.
  • 9Mangano EN, Litteljohn D, So R,et al. Interferon-y plays arole in paraquat-induced neurodegeneration involving oxida-tive and proinflammatory pathways [J]. Neurobiol Aging,2012,33(7): 1411-1426.
  • 10Lee FJ, Liu F, Pristupa ZB,et al. Direct binding and function-al coupling of alpha-synuclein to the dopamine transporters ac-celerate dopamine-induced apoptosis [J]. FASEB J, 2001,15(6): 916-926.

二级参考文献10

  • 1Zecca L, Zucca FA Albertini A,et al. Proposed dual role of neuromelanin in the pathogenesis of Parkinson's disease [J]. Neurology, 2006, 67 (7 suppl 2) : s8-11.
  • 2Zecca L, Costi P, Mecacci C, et al. The interaction of human substantia nigra neuromelanin with lipids and peptides [J]. J Neurochem, 2000, 74:1758-1765.
  • 3Zhang W, Wang T, Pei Z, et al. Aggregated alphasynuclein activates microglia: a process leading to disease progression in Parkinson's disease [J]. FASEB J,2005,19(6) : 533-542.
  • 4Qin L, Liu Y, Wang T, et al. NADPH oxidase mediates lipopolysaccharide-induced neurotoxicity and proinflammatory gene expression in activated microglia [J]. J Biol Chem, 2004, 279: 1415-1421.
  • 5Gao HM, Hong JS, Zhang W,et al. Synergistic dopaminergic neurotoxicity of the pesticide rotenone and inflammogen lipopolysaccharide: relevance to the etiology of Parkinson's disease [J]. J Neurosci, 2003, 23: 1228-1236.
  • 6Block ML, Zecca L, Hong JS. Microglia-mediated neurotoxicity: uncovering the molecular mechanisms [J]. Nat Rev Neurosci, 2007, 8(1) :57-69.
  • 7Stewart VC, Healea SJ. Nitric-induced mitochondrial dysfunction: implication for neurodegeneration [J]. Free Radic Biol Med, 2003, 34: 287-303.
  • 8Hunot S, Hirsch EC. Neuroinflammatory processes in Parkinson' s disease [J]. Ann Neuro, 2003,53 (3) : 49- (30.
  • 9Teismann P, Tieu K, Choi DK, et al. Cyclooxygenase- 2 is instrumental in Parkinson's disease neurodegeneration[J]. Proc Natl Acad Sci USA, 2003, 100(9): 5473-5478.
  • 10Wilms H, Rosenstiel P, Sievers J, et al. Activation of microglia by human neuromelanin is NF-kappaB dependent and involves p38 mitogen-activated protein kinase: implications for Parkinson' s disease [J]. FASEB J,2003,17(3): 500-502.

共引文献3

同被引文献99

  • 1张蓉,冯涛,刘萍,陈彪.帕金森病幻觉及其影响因素的研究[J].中华临床医师杂志(电子版),2011,5(19):5560-5566. 被引量:9
  • 2朱尚峰,金跃春.银杏叶提取物对脑组织及脑神经细胞活性的保护作用[J].中国临床康复,2006,10(23):146-148. 被引量:20
  • 3陈生弟.帕金森病治疗指南[J].中华神经科杂志,2006,39(6):409-412. 被引量:102
  • 4Hassouna I, Wickert H, Zimmermann M, et al. Increase in bax ex- pression in substantia nigra following 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine(MPTP) treatment of mice [ J ]. Neurosci Lett, 1996, 2004: 85-88.
  • 5XuBB, Liu CQ, Gao X, et al. Possible mechanisms of the protection of ginsenoside Re against MPTP-induced apoptosis in substantia nigra neurons of Parkinson's disease mouse model [ J ]. J Asian Nat Prod Res, 2005, 7:215 -224.
  • 6Brown KD, Clandio E, Siebenlist U. The roles of the classical and al- ternative nuclear factor-kb pathways : potential implications for auto- immunity and rheumatoid arthritis [ J ]. Arthritis Res Ther, 2008, 10:212 - 225.
  • 7Arumugam TV, Woodruff TM, Lathia JD, et al. Neuroprotection in stroke by complement inhibition and immunoglobnlin therapy [ J ] . Neuroscience, 2009, 158 : 1074 - 1089.
  • 8Karin M. Nuclear factor-kappaB in cancer development and progres- sion [ J ]. 2006, 441:431 - 436.
  • 9Toruner M, Femandez-Zapici M, Sha JJ, et al. Antianoikis effect of nuclear factor-kappaB through up-regulated expression of osteoprote- gerin, BCL-2, and IAP-1 [ J]. J Biol Chem, 2006, 28 : 8686 - 8689.
  • 10Bove J, Pefier C. Neurotoxin-based models of Parkinson's disease [J]. Neuroscience, 2012, 211 : 51 -76.

引证文献9

二级引证文献42

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部